CN1068523C - Medicine for treating cancer and its preparing technology - Google Patents
Medicine for treating cancer and its preparing technology Download PDFInfo
- Publication number
- CN1068523C CN1068523C CN98114273A CN98114273A CN1068523C CN 1068523 C CN1068523 C CN 1068523C CN 98114273 A CN98114273 A CN 98114273A CN 98114273 A CN98114273 A CN 98114273A CN 1068523 C CN1068523 C CN 1068523C
- Authority
- CN
- China
- Prior art keywords
- medicine
- cancer
- herba
- resolving
- treating cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 74
- 206010028980 Neoplasm Diseases 0.000 title claims description 43
- 201000011510 cancer Diseases 0.000 title claims description 31
- 229940079593 drug Drugs 0.000 title claims description 27
- 238000005516 engineering process Methods 0.000 title claims description 11
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 6
- 239000002674 ointment Substances 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 241000283956 Manis Species 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 5
- 241000269417 Bufo Species 0.000 claims description 5
- 241001608711 Melo Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims 1
- 230000001066 destructive effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 231100000614 poison Toxicity 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 239000003440 toxic substance Substances 0.000 abstract description 5
- 230000001093 anti-cancer Effects 0.000 abstract 2
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000084767 Potentilla indica Species 0.000 abstract 1
- 241000691155 Pteris multifida Species 0.000 abstract 1
- 240000009056 Saccharum arundinaceum Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 235000000336 Solanum dulcamara Nutrition 0.000 abstract 1
- 241000193241 Solanum dulcamara Species 0.000 abstract 1
- 235000002594 Solanum nigrum Nutrition 0.000 abstract 1
- 240000002307 Solanum ptychanthum Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 abstract 1
- 244000078912 Trichosanthes cucumerina Species 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 210000002637 putamen Anatomy 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 241000124079 Mylabris Species 0.000 description 19
- 230000003203 everyday effect Effects 0.000 description 6
- 230000007096 poisonous effect Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000003005 anticarcinogenic agent Substances 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010036772 Proctalgia Diseases 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004289 cerebral ventricle Anatomy 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to anticancer medicine, which has the components of reed-like sweetcane root, prism tuber, zedoary, arsenicum sublimatum, sphene, alum, hedyotis diffusa, barbed skullcap herb, root of subprostrate sophora, putamen manidis, black nightshade herb, Chinese brake herb, cowherb seed, snakegourd fruit, bittersweet herb and Indian mockstrawberry herb. The components are ground into fine powder, and the medicine of the present invention is formed. The medicine is mainly used for improving the organism immunity of patients. When the immunity of patients is improved, the anticancer medicine has the functions of softening and resolving clots, promoting blood circulation for removing blood stasis, clearing away heat, detoxicating, and resisting toxic substances with toxic substances. A treatment effective rate reaches 90% in approximate 200 cancerous patients in the treatment, and a recovery rate is 38%. The present invention has short course of treatment, and usually takes effect by half a month.
Description
The present invention relates to a kind of medicine for treating cancer and processing technology.
The medicine of existing treatment tumor is seldom seen the medicine that can effect a radical cure cancer, and the cancer healing ointment based on pain relieving is arranged, and its analgesic effect is more obvious, but can not effect a radical cure cancer.
The purpose of this invention is to provide a kind of raising body immunity, simultaneously hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, the short treating period for the treatment of the poisonous disease with poisonous drugs, the medicine for treating cancer and the processing technology thereof of instant effect.
The object of the present invention is achieved like this, the tumor of why growing, popular unusual with the QI and blood of human body, the phlegm-damp cohesion, long-pending and not diffusing, damage healthy energy is relevant, take hard masses softening and resolving at this cause, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, the scheme for the treatment of the poisonous disease with poisonous drugs is as follows: the present invention includes following component: in Mylabris weight is 1 part, and the parts by weight of all the other components are: Mylabris 1 rhizoma sparganic 2-10 Rhizoma Curcumae 2-10 Arsenicum sablimatum 1-6 Sal Nitri 1-10 Alumen 1-12 spends SHECAO 1-30 Herba Scutellariae Barbatae 1-40 Radix Sophorae Tonkinensis 1-45 Squama Manis 1-20 Herba Solani Nigri 1-40 Herba Pteridis Multifidae 2-40 Semen Vaccariae 1-40 Fructus Trichosanthis 1-40 Herba Solani Lyrati 1-40 Herba Duchesneae Indicae 1-50 in vain
Manufacture method of the present invention is with the common according to the above ratio pulverization of above-mentioned every medicine.
Instructions of taking: obey for each person every day three times, obey 15g at every turn, the morning, noon and afternoon service once.
With concrete case good effect of the present invention is described below, above-mentioned prescription of the present invention mainly is the body immunity that improves the patient, when improving immunity, take the medicine for treating cancer of hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, treating the poisonous disease with poisonous drugs, in the nearly 200 routine cancer patients that treated, the treatment effective percentage reaches 90%, and cure rate is 38%, short treating period, general two weeks promptly takes effect, and model case is as follows:
Patient Wang Liankuan, 68 years old, the man, patients with lung cancer is taken course of treatment of doctor's Zhou medicine, 98 year August 3 the Nikkei CT examination, the pulmonary carcinoma check, superior lobe of right lung leading portion Suo Ying, bronchial lumen is unobstructed, and the hilus pulumonis mediastinal lymph is little, with carry sheet contrast on July 9th, 98, the superior lobe of right lung pathological changes takes a turn for the better, ventricular system expansion, brain essence no abnormality seen.
Patient Wang Jingfa, man, 64 years old, identification card number 211224360116351, Zhaoyang Town, Changtu County, Liaoning Province Ma Jiadian people from village, gastroscopy is done by attached first hospital in 23 Nikkei Chinese Medical Sciences University Shenyang in 97 year October, be adenocarcinoma of stomach, beginning is 7 wheat harvesting periods in Shenyang, latter two month the state of an illness begin to worsen, pain unbearably, health is day by day become thin, thing does not feel like eating, feel not sleep well is also haveed a bone in one's leg on foot, is unable to leave the bed unexpectedly to the end, after that treatment of all big doctors, grabbed the medicine (month) of a course of treatment, taking medicine defecated time 15 days becomes black, and about 4-5 days color transfers to normally, after taking medicine three days, appetite increases, pain relief, and it is good especially to sleep, after one month, can do some muscular labor, appetite also increases, and can eat meal more than two bowls for every, do not have any reflection even eat Sorghum vulgare Pers. rice yet, HONGGUANG has been arranged on the face yet.
Patient Pan Shujuan, the woman, 75 years old, ID (identity number) card No. 210104280516032, being diagnosed as intestinal cancer in Liaoning Province tumour hospital for the first time has been middle and advanced stage, when tumour hospital sees, be late period once more, lymph has lump, and anus is all shut, not defecation 6 days, steam rises, belly is swollen, finish from the second day patient who grabs first pair of medicine big, eat up several pairs of medicines after, the state of an illness takes a turn for the better significantly, appetite increases, and proctalgia has alleviated, and can do a little portable work down, constantly dwindle through CT examination cancer enclosed mass and to come off, body weight increases day by day.
Patient Wang Youfu, man, 50 years old, identity card numbering 211226490322161,98 year January 7, esophageal carcinoma was suffered from the diagnosis of Nikkei Hospital Attached to Liaoning Inst. of Traditional Chinese Medicine, and May, the state of an illness increased the weight of, and bone shifts, lymph metastasis is taken behind Zhou doctor's the medicine 30 days CT examination once more, and lump disappears.
Patient's Ma Guoliang, 61 years old, man, identity card 211224371016271, Nikkei Central People's Hospital, Siping City was diagnosed as remnant gastric cancer 98 year June 8,3 place's tumors are arranged,, have only the last stomach pain of burning property in addition through two courses of treatment of medicine (one month is 1 course of treatment) of taking doctor Zhou of two places substantially, body weight is by 87.5 jin of 94 jins of rising to present (August 23) on June 12, through taking half course of treatment of medicine, various symptoms disappear, can participate in light physical labor again.
Embodiment 1:
The present invention includes following component: in Mylabris weight is 1 part, and the parts by weight of all the other components are: Mylabris 1 rhizoma sparganic 6 Rhizoma Curcumae 6 Arsenicum sablimatum 3 Sal Nitri 6 Alumen 7 are spent SHECAO 16 Herba Scutellariae Barbataes 21 Radix Sophorae Tonkinensiss 23 Squama Manis 11 Herba Solani Nigris 21 Herba Pteridis Multifidaes 21 Semen Vaccariae 21 Fructus Trichosanthis 21 Herba Solani Lyratis 21 Herba Duchesneae Indicaes 26 in vain
Manufacture method of the present invention is with the common according to the above ratio pulverization of above-mentioned every medicine.
Instructions of taking: obey for each person every day three times, obey 15g at every turn, the morning, noon and afternoon service once.
Embodiment 2:
The present invention includes following component: in Mylabris weight is 1 part, and the parts by weight of all the other components are: Mylabris 1 rhizoma sparganic 2 Rhizoma Curcumae 2 Arsenicum sablimatum 1 Sal Nitri 1 Alumen 1 is spent SHECAO 1 Herba Scutellariae Barbatae 1 Radix Sophorae Tonkinensis 1 Squama Manis 1 Herba Solani Nigri 1 Herba Pteridis Multifidae 2 Semen Vaccariae 1 Fructus Trichosanthis 1 Herba Solani Lyrati 1 Herba Duchesneae Indicae 1 in vain
Manufacture method of the present invention is with the common according to the above ratio pulverization of above-mentioned every medicine.
Instructions of taking: obey for each person every day three times, obey 15g at every turn, the morning, noon and afternoon service once.For quickening curative effect, shorten the course of treatment, above-mentioned medicinal guiding drug takes, and its concrete composition of guiding drug is composed as follows: the weight in above-mentioned medicine Mylabris is 1 part, and the parts by weight of the composition of guiding drug are
Herba Agrimoniae 1-25
Radix Notoginseng 1-15
Rhizoma Chuanxiong 11-25
Radix curcumae 1-10
Money is 1-15 recklessly
Pedicellus Melo 1-8
Radix Angelicae Sinensis 1-10
Fructus Zanthoxyli 1-15
The manufacture method of guiding drug is that 1 part of above-mentioned every medicine is ground into coarser powder in proportion, is 0.6-0.8 part with 4 parts of decoctings to medicinal liquid.
" return through " is that the traditional Chinese medical science recognizes that by long-term clinical practice some drugs has special therapeutical effect to the disease of some internal organs meridians, because each internal organs meridians pathological changes influences each other, and therefore when clinical application, the through focus of drug effect that the tying-in guiding drug is main.
Embodiment 3:
The present invention includes following component: in Mylabris weight is 1 part, and the parts by weight of all the other components are: Mylabris 1 rhizoma sparganic 10 Rhizoma Curcumae 10 Arsenicum sablimatum 6 Sal Nitri 10 Alumen 12 are spent SHECAO 30 Herba Scutellariae Barbataes 40 Radix Sophorae Tonkinensiss 45 Squama Manis 20 Herba Solani Nigris 40 Herba Pteridis Multifidaes 40 Semen Vaccariae 40 Fructus Trichosanthis 40 Herba Solani Lyratis 40 Herba Duchesneae Indicaes 50 in vain
Manufacture method of the present invention is with the common according to the above ratio pulverization of above-mentioned every medicine.
Instructions of taking: obey for each person every day three times, obey 15g at every turn, the morning, noon and afternoon service once.For quickening curative effect, shorten the course of treatment, above-mentioned medicinal guiding drug takes, and its concrete composition of guiding drug is composed as follows: the weight in above-mentioned medicine Mylabris is 1 part, and the parts by weight of the composition of guiding drug are:
Herba Agrimoniae 25
Radix Notoginseng 15
Rhizoma Chuanxiong 25
Radix curcumae 10
Money Hu 15
Pedicellus Melo 8
Radix Angelicae Sinensis 10
Fructus Zanthoxyli 15
The manufacture method of guiding drug is that 1 part of above-mentioned every medicine is ground into coarser powder in proportion, is 0.6-0.8 part with 4 parts of decoctings to medicinal liquid.
For body surface obvious lump is arranged, but external cancer resolving ointment, one pasted plaster 12 hours, had a rest afterwards 12 hours, change subsides again, the selected medicine of this cream has intensive function of promoting blood circulation to disperse blood clots, medicine directly is discharged into the tumor tissues surface from the soft tissue infiltration, improve around the tumor and the coagulation of focus fibrin, make its anticarcinogen be easy to permeate in tumor tissues, thereby improve the effect of killing cancerous cell, its ingredient is as follows, weight in above-mentioned Mylabris is 1 part, and the composition of cancer resolving ointment is as follows:
Bufo siccus 1-30
Radix Aconiti 1-20
Radix Aconiti Kusnezoffii 1-20
Borneolum Syntheticum 1-10
The processing technology of cancer resolving ointment is to add water with 1 part of above-mentioned medicine to decoct the state that drips into pearl get final product in the copper basin, and 50g whenever forces on.
Embodiment 4:
The present invention includes following component: in Mylabris weight is 1 part, and the parts by weight of all the other components are: Mylabris 1 rhizoma sparganic 2 Rhizoma Curcumae 2 Arsenicum sablimatum 1 Sal Nitri 1 Alumen 1 is spent SHECAO 1 Herba Scutellariae Barbatae 1 Radix Sophorae Tonkinensis 1 Squama Manis 1 Herba Solani Nigri 1 Herba Pteridis Multifidae 2 Semen Vaccariae 1 Fructus Trichosanthis 1 Herba Solani Lyrati 1 Herba Duchesneae Indicae 1 in vain
Manufacture method of the present invention is with the common according to the above ratio pulverization of above-mentioned every medicine.
Instructions of taking: obey for each person every day three times, obey 15g at every turn, the morning, noon and afternoon service once.For quickening curative effect, shorten the course of treatment, above-mentioned medicinal guiding drug takes, and the concrete composition of its guiding drug is composed as follows: the weight in above-mentioned medicine Mylabris is 1 part, and the parts by weight of the composition of guiding drug are
Herba Agrimoniae 1
Radix Notoginseng 1
Rhizoma Chuanxiong 11
Radix curcumae 1
Money Hu 1
Pedicellus Melo 1
Radix Angelicae Sinensis 1
Fructus Zanthoxyli 1
The manufacture method of guiding drug is that 1 part of above-mentioned every medicine is ground into coarser powder in proportion, is 0.6-0.8 part with 4 parts of decoctings to medicinal liquid.
For body surface obvious lump is arranged, but external cancer resolving ointment, one pasted plaster 12 hours, had a rest afterwards 12 hours, change subsides again, the selected medicine of this cream has intensive function of promoting blood circulation to disperse blood clots, medicine directly is discharged into the tumor tissues surface from the soft tissue infiltration, improve around the tumor and the coagulation of focus fibrin, make its anticarcinogen be easy to permeate in tumor tissues, thereby improve the effect of killing cancerous cell, its ingredient is as follows, weight in above-mentioned Mylabris is 1 part, and the composition of cancer resolving ointment is as follows:
Bufo siccus 1
Radix Aconiti 1
Radix Aconiti Kusnezoffii 1
Borneolum Syntheticum 1
The processing technology of cancer resolving ointment is the same.
Embodiment 5:
The present invention includes following component: in Mylabris weight is 1 part, and the parts by weight of all the other components are: Mylabris 1 rhizoma sparganic 10 Rhizoma Curcumae 10 Arsenicum sablimatum 6 Sal Nitri 10 Alumen 12 are spent SHECAO 30 Herba Scutellariae Barbataes 40 Radix Sophorae Tonkinensiss 45 Squama Manis 20 Herba Solani Nigris 40 Herba Pteridis Multifidaes 40 Semen Vaccariae 40 Fructus Trichosanthis 40 Herba Solani Lyratis 40 Herba Duchesneae Indicaes 50 in vain
Manufacture method of the present invention is with the common according to the above ratio pulverization of above-mentioned every medicine.
Instructions of taking: obey for each person every day three times, obey 15g at every turn, the morning, noon and afternoon service once.For quickening curative effect, shorten the course of treatment, above-mentioned medicinal guiding drug takes, and its concrete composition of guiding drug is composed as follows: the weight in above-mentioned medicine Mylabris is 1 part, and the parts by weight of the composition of guiding drug are:
Herba Agrimoniae 13
Radix Notoginseng 8
Rhizoma Chuanxiong 18
Radix curcumae 6
Money Hu 8
Pedicellus Melo 5
Radix Angelicae Sinensis 6
Fructus Zanthoxyli 8
The manufacture method of guiding drug is that 1 part of above-mentioned every medicine is ground into coarser powder in proportion, is 0.6-0.8 part with 4 parts of decoctings to medicinal liquid.
For body surface obvious lump is arranged, but external cancer resolving ointment, one pasted plaster 12 hours, had a rest afterwards 12 hours, change subsides again, the selected medicine of this cream has intensive function of promoting blood circulation to disperse blood clots, medicine directly is discharged into the tumor tissues surface from the soft tissue infiltration, improve around the tumor and the coagulation of focus fibrin, make its anticarcinogen be easy to permeate in tumor tissues, thereby improve the effect of killing cancerous cell, its ingredient is as follows, weight in above-mentioned Mylabris is 1 part, and the composition of cancer resolving ointment is as follows:
Bufo siccus 30
Radix Aconiti 20
Radix Aconiti Kusnezoffii 20
Borneolum Syntheticum 10
The processing technology of cancer resolving ointment is the same.
Embodiment 6:
Other compositions and manufacture method are constant, and the component of the cancer resolving ointment among the embodiment 5 can be changed into:
Bufo siccus 16
Radix Aconiti 11
Radix Aconiti Kusnezoffii 11
Borneolum Syntheticum 6
The processing technology of cancer resolving ointment is the same.
Claims (6)
1, a kind of medicine for treating cancer, it is characterized in that it is made up of following compositions in weight portion: the speckle insect destructive of the roots of seedlings 1 rhizoma sparganic 2-10 Rhizoma Curcumae 2-10 Arsenicum sablimatum 1-6 Sal Nitri 1-10 Alumen 1-12 spends SHECAO 1-30 Herba Scutellariae Barbatae 1-40 Radix Sophorae Tonkinensis 1-45 Squama Manis 1-20 Herba Solani Nigri 1-40 Herba Pteridis Multifidae 2-40 Semen Vaccariae 1-40 Fructus Trichosanthis 1-40 Herba Solani Lyrati 1-40 Herba Duchesneae Indicae 1-50 in vain
2, a kind of manufacture method of making the described medicine for treating cancer of claim 1 is characterized in that it being with the common according to the above ratio pulverization of above-mentioned every medicine.
3, medicine for treating cancer according to claim 1 is characterized in that its concrete composition is composed as follows to wherein adding guiding drug:
Herba Agrimoniae 1-25
Radix Notoginseng 1-15
Rhizoma Chuanxiong 11-25
Radix curcumae 1-10
Money is 1-15 recklessly
Pedicellus Melo 1-8
Radix Angelicae Sinensis 1-10
Fructus Zanthoxyli 1-15
4, a kind of processing technology of making the described medicine for treating cancer of claim 3, the manufacture method that it is characterized in that guiding drug are that 1 part of above-mentioned every medicine is ground into coarser powder in proportion, are 0.6-0.8 part with 4 parts of decoctings to medicinal liquid.
5,, it is characterized in that the composition of cancer resolving ointment is as follows to wherein adding cancer resolving ointment according to claim 1 or 3 described medicine for treating cancer:
Bufo siccus 1-30
Radix Aconiti 1-20
Radix Aconiti Kusnezoffii 1-20
Borneolum Syntheticum 1-10
6, a kind of processing technology of making the described medicine for treating cancer of claim 5, the manufacture method that it is characterized in that cancer resolving ointment are that the processing technology of cancer resolving ointment is to add water with 1 part of above-mentioned medicine to decoct the state that drips into pearl get final product in the copper basin, and 50g whenever forces on.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98114273A CN1068523C (en) | 1998-08-28 | 1998-08-28 | Medicine for treating cancer and its preparing technology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98114273A CN1068523C (en) | 1998-08-28 | 1998-08-28 | Medicine for treating cancer and its preparing technology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1246346A CN1246346A (en) | 2000-03-08 |
| CN1068523C true CN1068523C (en) | 2001-07-18 |
Family
ID=5223945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98114273A Expired - Fee Related CN1068523C (en) | 1998-08-28 | 1998-08-28 | Medicine for treating cancer and its preparing technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1068523C (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1144679A (en) * | 1996-06-05 | 1997-03-12 | 尚红鹰 | Medicine for treatment of multiple middle-advanced stage cancer |
| CN1152463A (en) * | 1996-09-10 | 1997-06-25 | 吴荫福 | Powder medicine for tumour |
| CN1157737A (en) * | 1996-10-24 | 1997-08-27 | 张文善 | ''Shanzhiai'' oral dosage |
| CN1176795A (en) * | 1996-09-18 | 1998-03-25 | 襄汾县肿瘤医院 | Traditional Chinese medicine- |
-
1998
- 1998-08-28 CN CN98114273A patent/CN1068523C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1144679A (en) * | 1996-06-05 | 1997-03-12 | 尚红鹰 | Medicine for treatment of multiple middle-advanced stage cancer |
| CN1152463A (en) * | 1996-09-10 | 1997-06-25 | 吴荫福 | Powder medicine for tumour |
| CN1176795A (en) * | 1996-09-18 | 1998-03-25 | 襄汾县肿瘤医院 | Traditional Chinese medicine- |
| CN1157737A (en) * | 1996-10-24 | 1997-08-27 | 张文善 | ''Shanzhiai'' oral dosage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1246346A (en) | 2000-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN1742939A (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN1049339C (en) | Chinese drug tumour removing powder and its preparation | |
| CN104524247B (en) | One treats migrainous medical composition and its use | |
| CN1272027C (en) | Desmodium preparation for treating urinary calculus, infection and cholelithiasis cholecy stolithiasis and chole cystitis and its production method | |
| CN1698748A (en) | Externally applied pure Chinese medicine for treating spondylitis ankylopoietica and arthritis and its preparation method | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN1068523C (en) | Medicine for treating cancer and its preparing technology | |
| CN1163251C (en) | Weishukang for treating gastrosis | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN1169555C (en) | A Chinese medicinal decoction pill for treating hepatitis B | |
| CN1060954C (en) | External use Chinese drug powder and its preparing method and medicinal pad | |
| CN1973850A (en) | Medicine composition for treating allergic rhinitis and its prepn process | |
| CN1152704C (en) | Anticancer oral liquid and its preparing process | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN1136894C (en) | Medicinal composition for treating tuberculosis and its preparing process | |
| CN1159054C (en) | Tongfuzhixie preparation | |
| CN1337252A (en) | Chinese medicine for treating chronic bronchitis | |
| CN1216622C (en) | Ointment for intervertebral disc | |
| CN1287847C (en) | Chinese medicine for treating acute and chronic nephritis and uremia | |
| CN1246019C (en) | Chinese medicine preparation for curing angitis | |
| CN1739678A (en) | Medicine for treating pain caused by wind, cold and wetness evils and its prepn | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN1189207C (en) | Chinese medicinal composition for improving human immunity and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20010718 Termination date: 20130828 |